FEBRUARY 5-7, 2024 | JW MARRIOTT TAMPA WATER STREET, TAMPA, FLORIDA

access!™ 2024 – aam annual meeting

AAM’s annual meeting Access! 2024 brings together policymakers, influential speakers and industry leaders to chart the future of generics and biosimilars. Discussions center around the business, breakthroughs and politics that shape our industry. It’s the opportunity to hear firsthand from world-renowned speakers and learn about where our industry is heading and what our future holds.

CHARTING A SUSTAINABLE PATH FOR GENERICS AND BIOSIMILARS

Join the leaders and decision-makers shaping the future of generics and biosimilars. Experience inspiration through candid discussions, fresh ideas, and meaningful interactions in a time of both challenges and promises. Don’t miss the opportunity to connect with fellow attendees and exhibitors at Access! 2024. Follow updates on X with #Access2024.

NETWORKING OPPORTUNITIES

Build connections at the conference with a full schedule of professional networking opportunities and social events. Whether you’re looking to advance your career or learn informally from an industry leader, this is your chance to strike up that pivotal conversation. Meet up with old colleagues or potential collaborators.

Access! 2023, Orlando, FL

Photo Album | Recap

Why You Should Attend

Hear insights on the latest global trends affecting your company and your future

Understand the interconnection between the U.S. and global markets

Gain access to breakthrough information about generics and biosimilars

Explore the latest developments in the generics and biosimilars industry

Interact with leaders in the industry

Experience a one-of-a-kind networking opportunity with industry peers

KEYNOTE SPEAKER HIGHLIGHTS

Jacqueline Corrigan-Curay, JD, M.D.

Principal Deputy Center Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Hon. Steve Southerland, II

Partner & Senior Vice President
Capitol Hill Consulting Group

Brian Sutter

Partner & CEO
Capitol Hill Consulting Group

Doug Long

Vice President, Industry Relations
IQVIA

Joe Alexander

Chief Strategy Officer
Capital Rx Inc.

Brian Hoffmann

President, U.S. Generics
Hikma Pharmaceuticals

Allan Oberman

President & Chief Executive Officer
Apotex Inc.

Arunesh Verma

President & CEO
Cipla North America

Jamie Metzl

Technology Futurist, Founder and Chair
OneShared.World

Punit Patel

President & Chief Executive Officer
Zydus Pharmaceuticals USA

Balaji Prasad, M.D.

Director
Barclays Investment Bank

David Gaugh, RPh

Interim President & CEO
AAM

EXPO

Showcase your company at Access! 2024. Don’t miss out on this highly-interactive, top-notch business environment which allows industry vendors to meet with generics and biosimilars industry executives. we offer out exhibitors abundant networking time with industry decision-makers. Reserve your space today! Space is limited.

SPONSORSHIP OPPORTUNITIES

Raise your company profile by participating in this prestigious event. Included in your sponsorship are custom branded digital assets you can use to promote your sponsorship of the event. You will also gain visibility to your brand through conference advertising prior to and during the event. For more information regarding sponsorship levels and benefits contact Jennifer Soup.

Platinum Sponsors

Apotex

Gold Sponsors

USP

Silver Sponsors

Bronze Sponsor

Patron Sponsor

Publication Partners

Biosimilars Review & Report
Life Sciences Review
access-2024-SM-general-1

GET THE LASTEST UPDATES

Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.

Skip to content